Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 732 participants.

Also called NCT01625442

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 732 participants (enrolled count) (from the registry)
Sponsor
Birjand University of Medical Sciences (from the registry)
Registry
  • NCT NCT01625442
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Iran (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01625442. Randomized; single masking; primary purpose treatment. Start 2010-01 (registry gives no type); primary completion 2011-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Crocus Sativus (Saffron) and Berberis Vulgaris (Barberry Fruit) in Metabolic Syndrome
Condition
Hypercholesterolemia
Condition
Hypertriglyceridemia
Condition
Hyperglycemia
Intervention (Drug)
Saffron tablet
Intervention (Drug)
Barberry tablet
Intervention (Drug)
Placebo
Lead sponsor
Birjand University of Medical Sciences (class: other)

Record details

Record id
cardio:ct-nct01625442
Content hash
b6ac4f9e3b0a2f2414bb08494aa40a14ea93eb830adb8eed1c93bd5ee9840651